Rapuano Christopher J
Cornea Service, Wills Eye Hospital, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pa, USA.
Trans Am Ophthalmol Soc. 2003;101:371-99.
To evaluate the use of high-frequency ultrasound biomicroscopy (UBM) in determining the depth of corneal pathology in eyes undergoing excimer laser phototherapeutic keratectomy (PTK) for primary or recurrent anterior stromal corneal dystrophies. Corneal clarity, visual acuity and refractive changes in eyes with and without an antihyperopia treatment were also analyzed.
Twenty eyes of 14 patients with anterior stromal corneal dystrophies were treated with PTK. Eyes were evaluated preoperatively and 6 to 8 weeks postoperatively with slit-lamp biomicroscopy, manifest refraction, keratometry, computerized corneal topography, ultrasound pachymetry, and UBM.
Nineteen of 20 corneas (95%) had greatly improved corneal clarity after PTK. Mean uncorrected Snellen vision improved from 20/102 to 20/69 and best corrected vision improved from 20/62 to 20/38. Nine eyes (45%) improved 2 or more lines of uncorrected vision, and 13 eyes (65%) improved 2 or more lines of best corrected vision. Mean change in spherical equivalent was just -0.92 diopters (D); however, the range was large (-13 to +3.88 D). UBM measurement of central corneal pathology did not correlate with the actual PTK ablation depth (P = .07). The amount of antihyperopia treatment did not correlate with changes in manifest refraction spherical equivalent, keratometry, or computerized corneal topography readings, but did correlate with length of time until corneal reepithelialization after PTK (P = .003).
PTK resulted in improvements in corneal clarity and visual acuity in most patients with superficial corneal stromal dystrophies. UBM was not an effective tool to accurately measure the depth of corneal pathology preoperatively. The combined approach of minimizing ablation depth and selective use of an antihyperopia treatment resulted in minimal mean change in spherical equivalent; however, the range was large. PTK is a very good minimally invasive technique to improve vision in eyes with anterior stromal corneal dystrophies.
评估高频超声生物显微镜(UBM)在确定接受准分子激光光治疗性角膜切削术(PTK)治疗原发性或复发性前基质角膜营养不良的眼睛中角膜病变深度的应用。还分析了接受和未接受远视治疗的眼睛的角膜清晰度、视力和屈光变化。
对14例前基质角膜营养不良患者的20只眼睛进行了PTK治疗。术前以及术后6至8周,使用裂隙灯生物显微镜、显验光、角膜曲率测量、计算机化角膜地形图、超声测厚仪和UBM对眼睛进行评估。
20只角膜中的19只(95%)在PTK治疗后角膜清晰度有显著改善。平均未矫正的斯内伦视力从20/102提高到20/69,最佳矫正视力从20/62提高到20/38。9只眼睛(45%)的未矫正视力提高了2行或更多,13只眼睛(65%)的最佳矫正视力提高了2行或更多。等效球镜度的平均变化仅为-0.92屈光度(D);然而,范围较大(-13至+3.88 D)。UBM测量的中央角膜病变与实际PTK消融深度不相关(P = 0.07)。远视治疗的量与显验光等效球镜度、角膜曲率测量或计算机化角膜地形图读数的变化不相关,但与PTK后角膜重新上皮化所需的时间相关(P = 0.003)。
PTK使大多数浅表角膜基质营养不良患者的角膜清晰度和视力得到改善。UBM不是术前准确测量角膜病变深度的有效工具。将消融深度降至最低并选择性使用远视治疗的联合方法导致等效球镜度的平均变化最小;然而,范围较大。PTK是改善前基质角膜营养不良眼睛视力的一种非常好的微创技术。